Fake doctor booked for selling expired drugs

T'puram: The drugs control department has initiated legal action against an alleged fake doctor in Kozhikode who provided expired medicines from his clinic. The raid at Marad medical centre, operating under Kozhikode Corporation, was conducted...

Best of the Week: GLP-1 Analysis, Career Opportunities for PhD Grads

This week, LCGC International published a variety of articles on hot topics in separation science. Below, we’ve highlighted some of the most popular articles that were published this week. Tools and Techniques for GLP-1 Analysis Kate Jones As...

Echosens and Boehringer Ingelheim Expand Partnership to Advance MASH Diagnosis and Care

As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of liver failure – affecting more than 250 million people worldwide – Echosens, the leader in non-invasive liver...

FDA Expands Moderna’s mRNA-1345 RSV Vaccine to Younger Adults

The FDA has expanded the approval of Moderna’s mRNA-1345 RSV vaccine to include people aged 18-59 years. This comes after last year’s initial approval of the vaccine for seniors 60 years of age and older in prevention of lower respiratory tract...

FDA Approves Amneal’s Prednisolone Acetate Ophthalmic Suspension for Steroid-Responsive Ocular Inflammation

Amneal Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved its prednisolone acetate ophthalmic suspension, 1%, a sterile topical anti-inflammatory agent intended for steroid-responsive ocular inflammation....

AstraZeneca, CSPC ink AI drug development deal for $110M upfront 

As­traZeneca is fur­ther tight­en­ing its re­la­tion­ship with Chi­na, an­nounc­ing a new re­search part­ner­ship with CSPC Phar­ma­ceu­ti­cals on Fri­day. CSPC will re­ceive $110 mil­lion up­front for …

AstraZeneca, CSPC Pharmaceuticals ink AI drug development deal for $110M upfront 

COPD, GERD Tied to Elevated Lung Cancer Risk Among Never-Smokers

Photo Credit: iStock.com/Mohammed Haneefa Nizamudeen Long-standing inflammatory disorders, including COPD and GERD, signal heightened risk for lung cancer among never-smokers, according to research. Among patients who have never...

ASCO Updates mCRPC Systemic Therapy Guideline

Photo Credit: iStock.com/Dr_Microbe A review of 22 trials led the American Society of Clinical Oncology (ASCO) to issue updates to its mCRPC systemic therapy guideline. For patients with metastatic castration-resistant prostate cancer (mCRPC), the...

Seismological Solution May Enable ED & ICU Ultrasound CT Use

Photo Credit: iStock.com/bymuratdeniz Ultrasound CT use in intensive care units and emergency departments may soon become a reality as the result of a recent seismology-based discovery. A seismology-based discovery from an interdisciplinary...

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

THURSDAY, June 12, 2025 (HealthDay News) — For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death protein-1-based immune checkpoint inhibitor (ICI), according to...

EveryBaby detects preterm birth risk 21% more accurately

The device measures cervical length from week 14 and outperforms transvaginal ultrasound. A prenatal device from startup EveryBaby is offering a major breakthrough in the early detection of premature birth risk—one of the most persistent and...

Surgeons treat carpal tunnel without skin incision

CEO secure CE mark for device that offers faster recovery without stitches. Swiss medtech companies Swibrace and Spirecut have developed a minimally invasive surgical device to treat carpal tunnel and trigger finger—two of the most common hand...

Capsida to Begin Phase 1/2 Trial of CAP-003 in Q3

Capsida Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CAP-003, its potential best-in-class intravenously (IV) administered gene therapy, to enter clinical...

Novo Nordisk Advances Amycretin for Weight Loss to Phase 3 Trials

Novo Nordisk announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies. The decision to advance subcutaneous and oral amycretin into phase 3 is based on...

FDA Approves MAVYRET as First Treatment for Acute Hepatitis C

AbbVie announced that the U.S. Food and Drug Administration (FDA) approved a label expansion for MAVYRET (glecaprevir/pibrentasvir), an oral pangenotypic direct acting antiviral (DAA) therapy. It is now approved for the treatment of adults and...

How I took my dental brand into Harrods

Zayba Sheikh, CEO of Ruh Dental, shares what it took to launch a dental clinic inside the world-renowned department store and what it means for patients, the brand and the future of wellness-led dentistry. Tell us about yourself and your...

Staying in control: real-time clinical insight for NHS orthodontics

Join Eva Lewin on Wednesday 18 June as she discusses real-time clinical insight for NHS orthodontics. This webinar offers a candid, practical look at how remote monitoring is being used to support NHS orthodontic delivery at scale. Specialist...

SpliceBio Raises $135 Million in Series B to Advance Gene Therapy for Stargardt Disease

SpliceBio has announced the successful closing of a $135 million Series B financing round to accelerate the clinical development of SB-007, the company’s lead gene therapy candidate for Stargardt disease. This inherited retinal condition, caused...

Empowering Postpartum Recovery: How Targeted Support Helps Mothers Reclaim Their Health and Comfort

Postpartum recovery takes time and care. New moms often face pain, fatigue, and core weakness long after birth. Support tools like the Momcozy Ergowrap Belly Band offer comfort, back support, and help with healing. No one warns you about how...